Biofactors' impact on diabetes prognosis | ||||
| Journal of Bioscience and Applied Research | ||||
| Volume 10, Issue 4, November 2024, Page 816-825 PDF (960.16 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jbaar.2024.393006 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Suha A. Muneam   1; Nada. A. Muneam 2; Ahmed Muayed3
| ||||
| 1Department of Chemistry and Biochemistry, Al-Iraqia University/ College of Medicine -Baghdad, Iraq. | ||||
| 2Department of Physiology and Medical Physics, Al-Iraqia University/ College of Medicine -Baghdad, Iraq | ||||
| 3Ministry of Higher Education and Scientific Research.Baghdad, Iraq | ||||
| Abstract | ||||
| Background: Diabetes mellitus (DM) is a chronic disease with a high prevalence globally, leading to significant health complications, particularly cardiovascular diseases (CVDs). A prevalent complication in diabetes is dyslipidemia, which is defined by high lipid levels and raises the risk of atherosclerosis and associated cardiovascular problems. Objective: the investigation was to discover cardiovascular risk factors unique to a patient's gender with type 2 diabetes mellitus (T2DM). Materials and Methods: A cross-sectional study of 85 individuals (47 women and 38 males) in two age groups (40-59 and 60-80) was carried out. SPSS version 22 assessed health markers such as ASCVD risk percentages, lipid profiles, and BMI. Results: There were significant differences between both genders regarding BMI, HDL cholesterol, triglycerides, CRI, and Atherogenic Index (AI), with women having higher levels of these markers than males but lower levels of AI and ASCVD risk. Conclusion: In T2DM patients, gender-specific approaches are required to manage cardiovascular risk, highlighting the significance of customized therapies based on lipid profiles and other risk factors. | ||||
| Keywords | ||||
| Biofactors; Diabetes Mellitus; Cardiovascular Risk; Gender Differences; atherosclerosis | ||||
|
Statistics Article View: 152 PDF Download: 120 |
||||
